Comment on "Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19".

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Coronavirus (SARS-CoV-2) and the risk of obesity for critically illness and ICU admitted: Meta-analysis of the epidemiological evidence.Obesity research & clinical practice
   Pooled it
2. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.International journal of molecular sciences · 2021
   Review
3. COVID-19 and diabetes; Possible role of polymorphism and rise of telemedicine.Primary care diabetes · 2021
   Review
4. Pulmonary Edema in COVID-19 Patients: Mechanisms and Treatment Potential.Frontiers in pharmacology · 2021
   Review
5. Do nutrients and other bioactive molecules from foods have anything to say in the treatment against COVID-19?Environmental research · 2020
   Article
6. Alpha-lipoic acid may protect patients with diabetes against COVID-19 infection.Medical hypotheses · 2020
   Article
7. A brief review of interplay between vitamin D and angiotensin-converting enzyme 2: Implications for a potential treatment for COVID-19.Reviews in medical virology · 2020
   Review
8. Comment on "Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19".Journal of medical virology · 2020
   Article
9. Reply to: "Reporting of all cardiac medications and their outcome in COVID-19".Journal of medical virology · 2020
   Article
10. Colchicine may not be effective in COVID-19 infection; it may even be harmful?Clinical rheumatology · 2020
    Article
11. Comment on "Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?"Diabetes research and clinical practice · 2020
    Article
12. Diabetes and COVID-19: evidence, current status and unanswered research questions.European journal of clinical nutrition · 2020
    Review
13. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.Theranostics · 2020
    Review
14. Can dapagliflozin have a protective effect against COVID-19 infection? A hypothesis.Diabetes & metabolic syndrome
    Article
15. Comment on "Hearing loss and COVID-19: A note".American journal of otolaryngology
    Article
16. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic.Diabetes & metabolic syndrome
    Article
17. Central involvement of SARS-CoV-2 may aggravate ARDS and hypertension.Journal of the renin-angiotensin-aldosterone system : JRAAS
    Article

Corrections and comments

• Comment on
  Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city, China.2020

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as